Xiaoxiao Y. Zhang
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Apatinib inhibits HTNV by stimulating TFEB-driven lysosome biogenesis to degrade viral protein.
Journal: Antiviral research
Published: December 26, 2024
A Novel HTNV Budding Inhibitor Interferes the Interaction Between Viral Glycoprotein and Host ESCRT Accessory Protein ALIX.
Journal: Journal of medical virology
Published: July 04, 2024
Evaluation of the outcomes of cochlear implant in children with auditory neuropathy
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: May 29, 2024
PKCδ serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 28, 2023
Guanylate-binding protein 1 inhibits Hantaan virus infection by restricting virus entry.
Journal: Journal of medical virology
Published: October 31, 2023
Whole-course management strategies for gastroesophageal reflux disease: an evidence mapping study based on clinical practice guidelines
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: April 18, 2023
A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.
Journal: Critical reviews in eukaryotic gene expression
Published: August 26, 2022
Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults.
Journal: BMC cardiovascular disorders
Published: August 04, 2022
In vitro Anti-Hantavirus Activity of Protein Kinase Inhibitor 8G1 Targeting AKT/mTOR/eIF4E Signaling Pathway.
Journal: Frontiers in microbiology
Published: February 21, 2022
Coumarin Derivative N6 as a Novel anti-hantavirus Infection Agent Targeting AKT.
Journal: Frontiers in pharmacology
Published: July 22, 2021
Nlrc3 Knockout Mice Showed Renal Pathological Changes After HTNV Infection.
Journal: Frontiers in immunology
Published: April 08, 2021
Last Updated: 09/26/2026